Episode 42: Journey to Leadership in Medical Writing
What does it really take to move into leadership in medical writing? Nidhi Johal, Medical Writing Manager of North America, and Kleopatra Kouroupaki, Senior Medical Writing manager, explore just that in this TriloTalk episode. They...
Episode 41: Breaking Down the One-Click Submission Dream
Everyone is talking about “one-click AI,” but is it real or just a conference buzzword? In this episode of TriloTalk, Lisa Chamberlain James, Senior Partner at Trilogy, and Vladimir Penkrat,...
Episode 40: The CDX files: Decoding Companion Diagnostic Devices
This episode of TriloTalk explores companion diagnostics and what makes them medical devices. Join Julia Forjanic Klapproth, Senior Partner at Trilogy, Laura Collada, Senior Medical Writing Manager at Trilogy, and Raquel Billiones, Director...
Episode 39: Unlocking the Power of Storytelling in Medical Writing: the PRISM Framework
Humans communicate through stories and medical writers help teams crystallize the story out of the data: this is the essence of what they bring to the table. Join Julia Forjanic Klapproth,...
Episode 38: Explaining the Evidence - Using AI for Lay Summaries of Clinical Trial Results
For TriloTalk episode 38, Lisa Chamberlain James, Senior Partner at Trilogy, and Sudipta Chakraborty, Head of Literacy & Plain Language Center of Excellence at Biogen, talk about how to use...
Episode 37: Primer on Writing for Drug-Delivery Systems
TriloTalk episode 37 focuses on a specific type of medical device, the drug-delivery system. Writing for drug-delivery systems is all about being fluent in two languages – drugs and devices....
Episode 36: Being Transparent About Clinical Trial Transparency
Clinical trial transparency is a delicate balance of getting the right data to the right resources at the right time. Senior Partner Lisa Chamberlain James sits down with the President...
Episode 35: Introducing the AMWA Apprentice Program Framework – A step-by-step guide to training medical writers
The demand for experienced medical writers is outpacing the availability of experienced writers. In TriloTalk episode 35, Julia Forjanic Klapproth, Senior Partner at Trilogy, and Kim Jochman, Senior Director of...
Episode 34: AI Agents - the future that's being used today!
For episode 34 of the TriloTalk podcast, Lisa Chamberlain James, Senior Partner at Trilogy, sits down with the AI Agent expert Nikesh Shah, VP and Global Head, Generative AI at...
Episode 33: Are Medical Devices from Venus and Pharmaceuticals from Mars? Important things to know when writing for medical devices.
This episode focuses on writing for medical devices. Playing Sherlock Holmes, conducting usability studies, following regulations, working closely with the manufacturers and much more are all in a day’s work...
Episode 32: Engaging the Clinical Trial Participant - using Plain Language in Informed Consent Forms
The Informed Consent Form is a participant’s first impression of a clinical trial so Lisa Chamberlain James and Ros Cheetham sit down to discuss how to make it the best...
Episode 31: What You Need to Know About AI Agents & Medical Writing
Join Julia Forjanic Klapproth as she gives a useful overview of what everyone is talking about these days – AI agents. You’ll hear about the benefits they bring and their...
Episode 30: Exploring the Role of Women in Science
It’s International Day of Women and Girls in Science! To celebrate, TriloTalk episode 30 is a conversation with Trilogy’s two female Senior Partners discussing what sparked their interest in science,...
Episode 29: What's Hot & What's Not for Regulatory Medical Writing in 2025
The rapidly growing industry of regulatory medical writing calls for a 2025 prediction podcast! Listen up for “What’s Hot and What’s Not” from our experts Lisa Chamberlain James, Julia Forjanic...
Episode 28: Exploring the Past, Present and Future of Orphan Drugs
Long time friends and industry colleagues, Lisa Chamberlain James with Trilogy and Cheryl Roberts with BioMarin Pharmaceutical sit down to discuss orphan drugs. They go over clinical trial hurdles, key...
Episode 27: Clinical Overviews - What are they & why are they so important?
Join Julia Forjanic Klapproth, Barbara Boggetti, and Bhawna Basin as they take a closer look into Clinical Overviews. Since many agree it’s one of the most interesting documents medical writers...
Episode 26: The Future of Lay Summaries - Leveraging AI for Patient-Friendly Language
Welcome back to TriloTalk! In this episode, Lisa Chamberlain James from Trilogy and Vladimir Penkrat and Ritesh Dogra from Indegene dive into the role and future of lay summaries. AI...
Episode 25: Exploring the Intersection of AI & Medical Writing
In this episode, Julia Forjanic Klapproth and Lisa Chamberlain James from Trilogy and Vladimir Penkrat and Tarun Mathur from Indegene chat about the intersection of AI and medical writing. They...
Episode 24: Navigating the Global Transparency Landscape
Welcome to Trilotalk Episode 24! In this episode, Douglas and Nidhi will take you through an overview of the recently introduced EU-CTR (Clinical Trial Regulation) – a hot topic in our...
Episode 23: Speaking of Buzzwords in Medical Writing, What About AI? – Part II
Welcome back to TriloTalk! As promised, we are continuing the conversation about buzzwords in medical writing. In this episode, our guests Lisa and Art explore the topic of medical writing...
